Key result
Nifedipine lacks robust evidence for tocolysis due to methodological flaws and under-assessed safety risks.
Why the study?
The safety aspects and tocolytic effectiveness of nifedipine have been under-assessed, with concerns about methodological flaws in existing studies.
Does nifedipine improve tocolytic effectiveness and safety in pregnant women at risk of preterm birth?
Population
Pregnant women at risk of preterm birth
Comparison
Nifedipine vs other tocolytic agents or placebo
Design
Review of over 40 studies including seven meta-analyses
Authors
Loading...
Clinicians should approach nifedipine tocolysis with caution; review challenges prior conclusions and leaves open need for rigorous trials.
Does nifedipine improve tocolytic effectiveness and safety in pregnant women at risk of preterm birth?
The use of nifedipine as a tocolytic agent requires caution, particularly in women with compromised cardiovascular conditions, due to risks of pulmonary edema and cardiac failure and methodological flaws in existing supportive studies.
Geijn et al. (2005) conducted a review in Preterm birth. Nifedipine was evaluated on Tocolytic effectiveness and safety. A review of over 40 studies on nifedipine for tocolysis found that conclusions favoring its use are not supported by the data due to methodological flaws and under-assessed safety risks.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: